 Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Get Free Report) major shareholder J.H. Whitney Equity Partners V sold 1,251,909 shares of the stock in a transaction that occurred on Friday, October 24th. The stock was sold at an average price of $9.00, for a total value of $11,267,181.00. Following the completion of the sale, the insider directly owned 19,292,787 shares of the company’s stock, valued at approximately $173,635,083. This trade represents a 6.09% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Large shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.
Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Get Free Report) major shareholder J.H. Whitney Equity Partners V sold 1,251,909 shares of the stock in a transaction that occurred on Friday, October 24th. The stock was sold at an average price of $9.00, for a total value of $11,267,181.00. Following the completion of the sale, the insider directly owned 19,292,787 shares of the company’s stock, valued at approximately $173,635,083. This trade represents a 6.09% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Large shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.
J.H. Whitney Equity Partners V also recently made the following trade(s):
- On Tuesday, October 21st, J.H. Whitney Equity Partners V sold 8,346,059 shares of Aveanna Healthcare stock. The stock was sold at an average price of $9.00, for a total value of $75,114,531.00.
Aveanna Healthcare Stock Up 0.5%
Shares of Aveanna Healthcare stock opened at $9.86 on Thursday. The company has a market cap of $2.06 billion, a PE ratio of 123.25 and a beta of 2.05. Aveanna Healthcare Holdings Inc. has a 52 week low of $3.67 and a 52 week high of $10.32. The business has a 50 day moving average price of $8.65 and a 200-day moving average price of $6.27.
Institutional Trading of Aveanna Healthcare
A number of large investors have recently bought and sold shares of AVAH. Summit Partners L P purchased a new stake in Aveanna Healthcare in the second quarter worth $50,477,000. Assenagon Asset Management S.A. purchased a new stake in Aveanna Healthcare in the third quarter worth $7,356,000. Connor Clark & Lunn Investment Management Ltd. increased its position in Aveanna Healthcare by 103.9% in the second quarter. Connor Clark & Lunn Investment Management Ltd. now owns 664,890 shares of the company’s stock worth $3,477,000 after buying an additional 338,746 shares during the last quarter. Squarepoint Ops LLC increased its position in Aveanna Healthcare by 207.0% in the second quarter. Squarepoint Ops LLC now owns 479,977 shares of the company’s stock worth $2,510,000 after buying an additional 323,656 shares during the last quarter. Finally, Nuveen LLC bought a new position in shares of Aveanna Healthcare in the first quarter worth $1,692,000. 87.96% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
A number of analysts recently commented on AVAH shares. Truist Financial dropped their price target on Aveanna Healthcare from $6.00 to $5.00 and set a “hold” rating on the stock in a report on Wednesday, July 16th. Barclays upgraded Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $5.50 to $9.50 in a report on Tuesday, August 19th. Weiss Ratings reiterated a “hold (c)” rating on shares of Aveanna Healthcare in a report on Wednesday, October 8th. Royal Bank Of Canada lifted their price target on Aveanna Healthcare from $8.00 to $10.00 and gave the stock a “sector perform” rating in a report on Friday, October 24th. Finally, UBS Group lifted their price target on Aveanna Healthcare from $8.00 to $9.00 and gave the stock a “neutral” rating in a report on Monday, October 13th. Three equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to MarketBeat, Aveanna Healthcare presently has a consensus rating of “Hold” and an average target price of $9.29.
Read Our Latest Analysis on Aveanna Healthcare
About Aveanna Healthcare
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.
Featured Articles
- Five stocks we like better than Aveanna Healthcare
- What Investors Need to Know About Upcoming IPOs
- These 3 High-Momentum ETFs Are Riding the Tech Wave
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Verizon Results Trigger Rebound in High-Yield Stock
- What is a support level?
- Picks & Shovels: Investing in the Physical Foundation of AI
Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

 
						